Health & Biotech
Health & Biotech
ECS stock rises on $4.9 million Cannvalate supply deal
Health & Biotech
MGC Pharma secures $10m capital raise from US and UK investors to advance development for its lead drug candidate, CimetrA
Health & Biotech
HealthKick Podcast: ASX biotech Dimerix gains momentum from involvement in multiple COVID-19 studies
Health & Biotech
ASX Health Stocks: After TGA approval in Australia, Telix now gets license to sell in Brazil
Health & Biotech
PharmAust’s upcoming Phase 1 clinical trials receive major boost with the production of smaller tablets
Health & Biotech
ASX Health Stocks: Rhythm Biosciences scores CE Mark approval, shares jump
Health & Biotech
As Biotron more than doubles on promising COVID results, which other ASX stocks are working on treatments?
Health & Biotech
Here are the ASX heart stocks fighting the number one killer disease in humans
Health & Biotech
ASX Health Stocks: Resapp gets TGA and CE mark approvals for its cough-counting app
Health & Biotech
Dr Boreham’s Crucible: Is Paul Hopper’s star power enough to get Radiopharm Theranostics beaming?
Health & Biotech
ScoPo’s Powerplays: Christmas rally runs out of puff, but market awaits crucial release from Neuren
Health & Biotech
ASX Health Stocks: Health app MedAdvisor maintains guidance, but share price slips 5pc
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.